Artiva BiotherapeuticsARTV
13F holders, Q3 2024 (September 30)49holders
1famous investor
$15.41avg. 13F price*
At the end of Q3 2024, 49 institutions reported holding Artiva Biotherapeutics Inc. (ARTV) in their 13F filings. The largest holders were Ra Capital Management, L.P. ($152.2M), 5AM Venture Management, LLC ($36.4M) and Venrock Adviser, LLC ($24.9M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Artiva Biotherapeutics Inc.
- CUSIP
- 04317A107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 48 | $306.5M |
| Exits | 0 | $0 |
Ownership 49 holders
| Ra Capital Management, L.P. | 1.76% | New | 9,853,302 | $152.2M |
| 5AM Venture Management, LLC | 7.51% | New | 2,353,304 | $36.4M |
| Venrock Adviser, LLC | 1.30% | New | 1,609,569 | $24.9M |
| venBio Partners LLC | 12.08% | New | 1,519,971 | $23.5M |
| Capital World Investors | 0.00% | New | 915,386 | $14.1M |
| Vanguard Group Inc. | 0.00% | New | 841,005 | $13.0M |
| BlackRock, Inc. | 0.00% | — | 837,613 | $12.9M |
| Franklin Resources Inc. | 0.00% | New | 520,301 | $7.4M |
| Geode Capital Management, LLC | 0.00% | New | 308,930 | $4.8M |
| Samsara Biocapital, LLC | 0.87% | New | 291,666 | $4.5M |
| Woodline Partners LP | 0.04% | New | 283,124 | $4.4M |
| Wellington Management Group LLP | 0.00% | New | 194,108 | $2.9M |
| RTW Investments, LP | 0.03% | New | 148,844 | $2.3M |
| Logos Global Management LP | 0.24% | New | 145,089 | $2.1M |
| Northern Trust Corp. | 0.00% | New | 112,777 | $1.7M |
| Cormorant Asset Management, LP | 0.08% | New | 103,633 | $1.6M |
| Alyeska Investment Group, L.P. | 0.01% | New | 100,000 | $1.5M |
| Citadel Advisors | 0.00% | New | 103,635 | $1.5M |
| State Street Corp. | 0.00% | New | 86,559 | $1.3M |
| Acuta Capital Partners, LLC | 0.55% | New | 44,000 | $680K |
| EcoR1 Capital, LLC | 0.02% | New | 41,453 | $640K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 40,293 | $623K |
| Morgan Stanley | 0.00% | New | 39,953 | $617K |
| Bank of New York Mellon Corp | 0.00% | New | 31,209 | $482K |
| Norges Bank | 0.00% | New | 30,000 | $464K |
| Goldman Sachs Group Inc. | 0.00% | New | 29,547 | $457K |
| Barclays PLC | 0.00% | New | 19,616 | $303K |
| Nuveen Asset Management, LLC | 0.00% | New | 18,611 | $288K |
| Bank of America Corp. | 0.00% | New | 17,818 | $275K |
| Rhumbline Advisers | 0.00% | New | 14,829 | $229K |
| JPMorgan Chase & Co. | 0.00% | New | 10,726 | $166K |
| Citigroup Inc. | 0.00% | New | 10,181 | $157K |
| MetLife Investment Management, LLC | 0.00% | New | 8,733 | $135K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | New | 7,659 | $118K |
| Corebridge Financial, Inc. | 0.00% | New | 7,515 | $116K |
| UBS Group AG | 0.00% | New | 6,618 | $102K |
| Wells Fargo & Company | 0.00% | New | 5,255 | $81K |
| New York State Common Retirement Fund | 0.00% | New | 2,937 | $45K |
| BNP Paribas Financial Markets | 0.00% | New | 2,728 | $42K |
| STRS Ohio | 0.00% | New | 2,600 | $40K |
| Royal Bank of Canada | 0.00% | New | 2,061 | $32K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 1,424 | $22K |
| Legal & General Group Plc | 0.00% | New | 1,393 | $22K |
| Mark Sheptoff Financial Planning, LLC | 0.01% | New | 1,300 | $20K |
| California State Teachers Retirement System | 0.00% | New | 1,041 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 720 | $11K |
| Amalgamated Bank | 0.00% | New | 480 | $7K |
| FMR LLC | 0.00% | New | 160 | $2K |
| Sterling Capital Management LLC | 0.00% | — | 31 | $479 |
"% of holder's portfolio" is ARTV's weight in each manager's 13F, not the share of Artiva Biotherapeutics Inc. the manager owns.